Skip to Content

AP National News

BioNTech to work with Senegal, Rwanda to make mRNA vaccines

By CARLEY PETESCH Associated Press DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which developed and produces the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction on the facilities will start in mid-2022.

Continue Reading